. Trials. Q3  Q4  Q5  Q6  Q7  Q8  Q9  Q10  Q11  Q12  Q13  Q14  Q15  Q16  Q17  Q18  Q19  Q20  Q21  Q22  Q23  Q24  Q25  Q26 Q1: Is the hypothesis/aim/objective of the study clearly described?
Q2: Are the main outcomes to be measured clearly described in the Introduction or Methods section?
Q3: Are the characteristics of the patients included in the study clearly described?
Q4: Are the interventions of interest clearly described?
Q5: Are the distributions of principal confounders in each group of subjects to be compared clearly described?
Q6: Are the main findings of the study clearly described?
Q7: Does the study provide estimates of the random variability in the data for the main outcomes?
Q8: Have all important adverse events that may be a consequence of the intervention been reported?
Q9: Have the characteristics of patients lost to follow-up been described? Q10: Have actual probability values been reported (e.g. 0.035 rather than <0.05) for the main outcomes except where the probability value is less than 0.001?
Q11: Were the subjects asked to participate in the study representative of the entire population from which they were recruited?
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2 of 4 Q12: Were those subjects who were prepared to participate representative of the entire population from which they were recruited?
Q13: Were the staff, places, and facilities where the patients were treated, representative of the treatment the majority of patients receive?
Q14: Was an attempt made to blind study subjects to the intervention they have received?
Q15: Was an attempt made to blind those measuring the main outcomes of the intervention?
Q16: If any of the results of the study were based on "data dredging", was this made clear?
Q17: In trials and cohort studies, do the analyses adjust for different lengths of follow-up of patients, or in case-control studies, is the time period between the intervention and outcome the same for cases and controls?
Q18: Were the statistical tests used to assess the main outcomes appropriate?
Q19: Was compliance with the intervention/s reliable? Q20: Were the main outcome measures used accurate (valid and reliable)?
Q21: Were the patients in divergent intervention groups (trials and cohort studies) or were the cases and controls (case-control studies) recruited from the same population?
Q22: Were study subjects in divergent intervention groups (trials and cohort studies) or were the cases and controls (case-control studies) recruited over the same period of time?
Q23: Were study subjects randomized to intervention groups?
Q24: Was the randomized intervention assignment concealed from both patients and health care staff until recruitment was complete and irrevocable?
Q25: Was there adequate adjustment for confounding in the analyses from which the main findings were drawn? Q26: Were losses of patients to follow-up taken into account?
Q27: Did the study have sufficient power to detect a clinically important effect where the probability value for a difference being due to chance is less than 5%? Q3: Is there congruity between the research methodology and the methods used to collect data?
